Now in its third edition, Pharmacology in Clinical Practice has been updated to ensure it remains up-to-date and relevant.

Particular care has been taken to simplify and clarify difficult concepts by explaining the links between pharmacology and physiology by providing definitions of new concepts, and using plain language for ease of understanding. Fundamental concepts, such as pharmacodynamics and pharmacokinetics, are well covered in a matter that is accessible and clear. Individual chapters cover the various systems of the body.

Updates include:

• A colour plate to illustrate the links between pharmacology and physiology
• Additional information on side-effects, contra-indications and patient education for groups of drugs
• A guide on how to access this information, to assist with exam preparation and nursing practice
• An updated chapter on nursing management of drug preparations and treatment
• An updated chapter on clinical applications
• A chapter on the legal framework for dispensing and prescribing.

Volksgeneeskuns in Suid-Afrika is ’n versameling van 8705 boererate en het die eerste keer in 1965 verskyn. Vandag, 60 jaar later, lyk die mediese en farmakologiese landskap totaal anders. Daarom is dit so interessant – en soms lagwekkend – om te sien hoe vinnig ons mediese en farmakologiese kennis intussen gevorder het.

Die versameling bevat rate wat op bygeloof of tradisionele mondelinge oorlewering berus. Ander rate maak staat op veldkennis en die botaniese name van middels word verstrek. Daar word raat uitgedeel vir kwale van asma tot ylhoofdigheid.

“Vermaaklike oomblikke is talryk vir die moderne leser – en die algemene gebruik van hondebloed, velle van pas geslagte katte, luislange en dies meer, laat ’n mens verbysterd – tot jy besef met hoeveel radeloosheid daar voor sekere siektes te staan gekom is.” Dr. Dione Prinsloo – geskiedkundige.

With the range of psychotropic drugs expanding and the usages of existing medications diversifying, we are pleased to present the Seventh Edition of the world's best-selling formulary in psychopharmacology. The new edition features nine new compounds as well as information about several new formulations of existing drugs. Many important new indications are covered for existing drugs, as are updates to the profiles of the entire content and collection, including new injectable and transdermal formulations, as well as updated warnings and indications. The Pearls have all been refreshed and the antipsychotics section has been completely revised. With its easy-to-use, full-colour template-driven navigation system, Prescriber's Guide combines evidence-based data with clinically informed advice to support everyone who is prescribing in the field of mental health.

For courses in Pharmacology. PHARMACOLOGY: CONNECTIONS TO NURSING PRACTICE, 2/e tightly links pharmacology to nursing practice and patient care, recognizing that for nurses, pharmacology is not an abstract academic discipline but rather a critical tool to prevent disease and promote healing and wellness. It offers unsurpassed features designed to illuminate connections between pharmacology and practice, from patient scenarios and practice applications to coverage of lifespan considerations, patient education, alternative therapies, and gender/cultural influences. Nine additional units illuminate the actions of individual drugs on each body system and disease. Learning is simplified through the use of prototype drugs, as well as outstanding full-color illustrations, complemented by 45 web-based animations. This edition covers 30+ new drugs, and offers updated information about dosages, indications, and adverse effects throughout, including Black Box Warnings.

'Poignant and lyrical...Slater's experience makes her a convincing travel guide into the history, creation and future of psychotropics.' - The New York Times Book Review A groundbreaking and revelatory story of the psychotropic drugs that have shaped our minds and our reality. As our approach to mental illness has oscillated from biological to psychoanalytical and back again, so have our treatments. With the rise of psychopharmacology, an ever-increasing number of people throughout the globe are taking a psychotropic drug, yet nearly seventy years after doctors first began prescribing them, we still don't really know exactly how or why they work - or don't work - on what ails our brains. In The Drugs that Changed Our Minds, Lauren Slater offers an explosive account not just of the science but of the people - inventors, detractors and consumers - behind our narcotics, from the earliest, Thorazine and Lithium, up through Prozac, Ecstasy, 'magic mushrooms', the most cutting-edge memory drugs and neural implants. In so doing, she narrates the history of psychiatry itself and illuminates the signature its colourful little capsules have left on millions of brains worldwide, and how these wonder drugs may heal us or hurt us. Praise for the book: 'A powerful new book' - The Daily Mail 'The messy history and brave future of psychotropic drugs' - O Magazine 'Vivid and thought-provoking' - Harper's Magazine 'Ambitious...Slater's depictions of madness are terrifying and fascinating' - USA Today 'Vigorous research and intimate reflection...highly compelling' - Kirkus

This book is for personalized medicine as a prescription of specific treatments and therapeutics best suited for an individual and considers genetic as well as environmental factors that influence responses to therapy. Best approaches are described for integration of all available technologies for optimizing the therapy of individual patients. This comprehensive third edition covers the latest advances in personalized medicine and several chapters are devoted to various specialties, particulary cancer which is the largest area of application. The book discusses the development of personalized medicine and various players in it such as companies, academic institutions, the government, and the public as the consumer of healthcare. Additionally, the roles of bioinformatics, electronic health records, and digital technologies for personalized medicine are discussed. Textbook of Personalized Medicine, 3rd Edition serves as a convenient source of information for students at many levels and in a wide range of fields, including physicians, scientists, and decision makers in the biopharmaceutical and healthcare industries.

'Bad Science' hilariously exposed the tricks that quacks and journalists use to distort science, becoming a 400,000 copy bestseller. Now Ben Goldacre puts the $600bn global pharmaceutical industry under the microscope. What he reveals is a fascinating, terrifying mess. Doctors and patients need good scientific evidence to make informed decisions. But instead, companies run bad trials on their own drugs, which distort and exaggerate the benefits by design. When these trials produce unflattering results, the data is simply buried. All of this is perfectly legal. In fact, even government regulators withhold vitally important data from the people who need it most. Doctors and patient groups have stood by too, and failed to protect us. Instead, they take money and favours, in a world so fractured that medics and nurses are now educated by the drugs industry. The result: patients are harmed in huge numbers. Ben Goldacre is Britain's finest writer on the science behind medicine, and 'Bad Pharma' is the book that finally prompted Parliament to ask why all trial results aren't made publicly available - this edition has been updated with the latest news from the select committee hearings. Let the witty and indefatigable Goldacre show you how medicine went wrong, and what you can do to mend it.

With the range of psychotropic drugs expanding and the usages of existing medications diversifying, we are pleased to present the Seventh Edition of the world's best-selling formulary in psychopharmacology. The new edition features nine new compounds as well as information about several new formulations of existing drugs. Many important new indications are covered for existing drugs, as are updates to the profiles of the entire content and collection, including new injectable and transdermal formulations, as well as updated warnings and indications. The Pearls have all been refreshed and the antipsychotics section has been completely revised. With its easy-to-use, full-colour template-driven navigation system, Prescriber's Guide combines evidence-based data with clinically informed advice to support everyone who is prescribing in the field of mental health.

Now in its sixth edition, the Handbook of Drugs in Intensive Care is the essential guide to using drugs safely and effectively in the intensive care setting. The book is split into two sections: an A-Z guide to the drugs available, and concise notes on the key topics and situations faced on a daily basis. The A-Z section provides succinct information on each drug including uses, limitations, administration directions and adverse effects. The second section details practice guidelines such as insulin therapy, Parkinson's disease therapy when nil-by-mouth, and drug dosing in renal failure. This revised edition includes seventeen new drug monographs and covers several new topics, including blood glucose management. A colour chart showing drug compatibility for intravenous administration is included at the back of the book. Presented in a concise, compact format, this book is an invaluable resource for doctors, nurses, pharmacists and other healthcare professionals caring for critically ill patients.

Emergency management of acute poisoning is an emergency medicine short course that equips emergency personnel to assess acutely poisoned patients rapidly and accurately. This title is also valuable to nursing staff, senior pre-hospital health professionals and general practitioners. It provides a framework within which emergency personnel can safely work without being swamped by unnecessary details. The more commonly encountered cases of poisoning are discussed with guidelines for appropriate 'syndrome based' management of unknown toxicity while further investigations are being conducted.

This detailed book aims to provide readers with critical information to accomplish the synthesis of nanosystems for the purpose of supramolecular entities complexing with drugs, targeted drug delivery system characterization, as well as the study of the physical-chemical interactions that govern the stability and properties of these systems. Beginning with a collection of chapters on drug delivery platforms such as cyclodextrins, micelles, liposomes, polymeric, nanotubes, and more, the volume continues with coverage of the study of nanotechnology systems using different biophysical techniques such as DSC, ITC, solid and liquid NMR spectroscopy, and electrochemistry. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and practical, Supramolecules in Drug Discovery and Drug Delivery: Methods and Protocols serves as an ideal guide for researchers working toward drug delivery mechanisms that can tailor their physical chemical properties and enhance their efficacy, while retaining their structures intact.

This book reviews the imaging features associated with selected classes of pharmaceuticals and drugs on brain, head and neck, and spine and explains the implications of the imaging findings for the neuroradiologist and the clinician. Some agents produce characteristic abnormalities with distinctive imaging features, while others have a spectrum of manifestations on imaging. Still further agents produce rather nonspecific changes on imaging, requiring a differential diagnosis. In this book, informative cases are depicted by rich images, with concise accompanying explanatory text that reviews the class of agent and the mechanism of action and discusses image interpretation and its significance.

Published by Sinauer Associates, an imprint of Oxford University Press. The first edition of Psychopharmacology: Drugs, the Brain, and Behavior, published in 2004, was unique in its breadth of coverage ranging from historical accounts of drug use to clinical and preclinical behavioral studies to the latest research on drug effects in transgenic mouse models. Student engagement with the material is fostered by opening each chapter with a relevant vignette and by providing breakout boxes presenting novel and, in some cases, controversial topics for special discussion. Box themes include History of Psychopharmacology, Pharmacology in Action, Clinical Applications, and The Cutting Edge. The book is lavishly illustrated with full-color photographs and line art depicting important concepts and experimental data. Psychopharmacology: Drugs, the Brain, and Behavior, Second Edition is appropriate for undergraduate or beginning level graduate courses in psychopharmacology or drugs and behavior that emphasize relationships between the behavioral effects of psychoactive drugs and their mechanisms of action.

The Art, Science, and Technology of Pharmaceutical Compounding, 6th Edition has been completely revised and covers all aspects of pharmaceutical compounding. Featured are the regulations,technology, scientific foundation, and clinical consulting aspects of the dosage forms that can be compounded. It also contains example formulas for all dosage forms along with the ingredients, quantities, use of each ingredient, and instructions for preparation. In addition to formulation development including flavoring, sweetening, preservation and compliance and compatibility considerations, quality control and areas of potential errors are also presented. More than ever, there is a need for a practical compounding reference that integrates the science and practice of compounding while emphasizing the need for caution, innovation, and patient counseling. KEY FEATURES: Covers all aspects of nonsterile and sterile as well as nonhazardous and hazardous compounding. Blends the scientific and technologic aspects of compounding to support an understanding of the importance of each compounded dosage form. Presents different technologies for compounding various dosage forms, as well as example. Formulations for all dosage forms presented in the book. Features an entirely new chapter emphasizing the pharmacist's role in addressing incompatibilities and their potential clinical effects.

Compiled with the advice of clinical experts and continually updated to reflect the latest evidence from credible sources worldwide, the new edition of the British National Formulary 80 (BNF 80) provides up-to-date guidance on prescribing, dispensing, and administering medicines. Access to the latest edition of the BNF is vital for healthcare professionals, as it reflects current best practice as well as legal and professional guidelines relating to the uses of medicines.NICE has accredited the editorial process used by the British National Formulary to produce its resources.

Master the intricacies of pharmaceutical design and production! Succeed in your course with Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems , the most comprehensive source on this subject available today! Reflecting the CAPE, APhA, and NAPLEX (R) competencies, this trusted resource explores the interrelationships between pharmaceutical and biopharmaceutical principles, product design, formulation, manufacture, compounding, and the clinical application of the various dosage forms in patient care, as well as regulations and standards governing the manufacturing and compounding of pharmaceuticals. Discover the latest on dosage form design and formulation , good compounding practices , quality assurance for pharmacy-prepared sterile products , and much more with meticulous updates from cover to cover. Learn about clinical pharmaceutics with a brand-new chapter on this important topic, as well as added content throughout. See pharmaceutical concepts in action through the two case studies (one pharmaceutical and one clinical) in each chapter on dosing forms. Practice what you learn using the group and individual activities in Applying the Principles and Concepts sections in every chapter. Master important underlying pharmaceutical principles through Physical Pharmacy Capsules . Study efficiently with Chapter Objectives and Chapter at a Glance sections that highlight the key material you need to master. New addition to the appendix includes, review of active ingredient considerations in dosing.

Here, the best-selling author and renowned researcher, K. C. Nicolaou, presents around 40 natural products that all have an enormous impact on our everyday life. Printed in full color throughout with a host of pictures, this book is written in the author's very enjoyable and distinct style, such that each chapter is full of interesting and entertaining information on the facts, stories and people behind the scenes. Molecules covered span the healthy and useful, as well as the much-needed and extremely toxic, including Aspirin, urea, camphor, morphine, strychnine, penicillin, vitamin B12, Taxol, Brevetoxin and quinine.
A veritable pleasure to read.

Offering a basis for further research into the interactions of hosts and pathogens, this work gathers up-to-date findings, and details basic structures, functions and immunology. It provides descriptions of a variety of experimental endotoxin neutralizing agents, as well as a guide to clinical research initiatives and the latest treatments.

Describes the immunological aspects of blood transfusion medicine, examining the immuno-chemistry of blood group antigens, the immune destruction of cells, correlations between blood groups and disease, and the effect transfusion-induced retroviral infection has on immune response.

In 24 contributed chapters, 37 international specialists describe the latest developments in research on snake venom including different types of venoms and toxins, actions, antidotes, and applications and summarize what is known to date on Gila monster and frog toxins. Some 70 tables provide essent

Covers fundamentals of peptide and protein drug delivery. This reference/text includes such considerations as synthesis, physical chemistry and biochemistry, analysis, proteolytic and transport constraints, pharmacokinetics, and pharmacodynamics as well as bioavailability from routes of administration.

A drug that is simultaneously affordable, devoid of severe side effects, and applicable to a wide range of diseases is not often found in the modern pharmaceutical landscape. But as medical professionals and researchers alike continue to discover, Low Dose Naltrexone (LDN) boasts this remarkable combination. LDN, originally prescribed in higher doses as a treatment for opioid addiction, works by blocking opioid receptors, thereby stimulating the production of endorphins, mitigating the inflammatory process, and stabilizing the immune response. Prescribed off-label and administered in small daily doses, this generic drug has proven useful in treating many different ailments. Expanding on the information presented in The LDN Book Volume 1-which showcased LDN's efficacy in treating conditions such as lupus, thyroiditis, autism spectrum disorder, and chronic fatigue-Volume 2 highlights the latest clinical trials, case studies, and research on LDN. More than a dozen medical professionals explain how they are using LDN to help patients suffering from chronic pain, Parkinson's disease, dermatologic conditions, traumatic brain injury, Lyme disease, and more. The LDN Book Volume 2 is both a resource for practitioners, pharmacists, and patients, and a renewed call for further research on a little-known drug with big potential.